Christopher LiPuma is an Investment Professional at Fortress Investment Group. Chris’ career has focused on advising and investing in late-stage life sciences companies. Prior to Fortress, he was a member of the OrbiMed Advisors structured investments team which managed ~$2.0 billion. The team at OrbiMed worked closely with public and private companies to finance the development, launch, or acquisition of innovative products. Chris’ experience includes investments in multiple therapeutic areas, medical devices, and diagnostics. Prior to joining OrbiMed, he was at Cowen Healthcare Royalty Partners. At Cowen, he invested in a range of transactions including royalty monetizations, growth equity investments, and off-balance sheet financings for larger pharmaceutical companies. Prior to Cowen, he was an analyst in the investment banking groups of Leerink Partners.